These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22411251)

  • 1. Oxidative stress and mitochondrial dysfunction in Down syndrome.
    Pagano G; Castello G
    Adv Exp Med Biol; 2012; 724():291-9. PubMed ID: 22411251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome.
    Gulesserian T; Seidl R; Hardmeier R; Cairns N; Lubec G
    J Investig Med; 2001 Jan; 49(1):41-6. PubMed ID: 11217146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome.
    Shukkur EA; Shimohata A; Akagi T; Yu W; Yamaguchi M; Murayama M; Chui D; Takeuchi T; Amano K; Subramhanya KH; Hashikawa T; Sago H; Epstein CJ; Takashima A; Yamakawa K
    Hum Mol Genet; 2006 Sep; 15(18):2752-62. PubMed ID: 16891409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-amyloid, oxidative stress and down syndrome.
    Lott IT; Head E; Doran E; Busciglio J
    Curr Alzheimer Res; 2006 Dec; 3(5):521-8. PubMed ID: 17168651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
    Annerén G; Edman B
    APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction and Down's syndrome.
    Arbuzova S; Hutchin T; Cuckle H
    Bioessays; 2002 Aug; 24(8):681-4. PubMed ID: 12210526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria as pharmacological targets in Down syndrome.
    Valenti D; Braidy N; De Rasmo D; Signorile A; Rossi L; Atanasov AG; Volpicella M; Henrion-Caude A; Nabavi SM; Vacca RA
    Free Radic Biol Med; 2018 Jan; 114():69-83. PubMed ID: 28838841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome.
    Pallardó FV; Lloret A; Lebel M; d'Ischia M; Cogger VC; Le Couteur DG; Gadaleta MN; Castello G; Pagano G
    Biogerontology; 2010 Aug; 11(4):401-19. PubMed ID: 20237955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRIP1/RIP140 siRNA-mediated attenuation counteracts mitochondrial dysfunction in Down syndrome.
    Izzo A; Manco R; Bonfiglio F; Calì G; De Cristofaro T; Patergnani S; Cicatiello R; Scrima R; Zannini M; Pinton P; Conti A; Nitsch L
    Hum Mol Genet; 2014 Aug; 23(16):4406-19. PubMed ID: 24698981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.
    Coskun P; Helguera P; Nemati Z; Bohannan RC; Thomas J; Samuel SE; Argueta J; Doran E; Wallace DC; Lott IT; Busciglio J
    J Alzheimers Dis; 2017; 55(2):737-748. PubMed ID: 27802222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial defects in transgenic mice expressing Cu,Zn superoxide dismutase mutations: the role of copper chaperone for SOD1.
    Son M; Elliott JL
    J Neurol Sci; 2014 Jan; 336(1-2):1-7. PubMed ID: 24269091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.
    Izzo A; Mollo N; Nitti M; Paladino S; Calì G; Genesio R; Bonfiglio F; Cicatiello R; Barbato M; Sarnataro V; Conti A; Nitsch L
    Mol Med; 2018 Mar; 24(1):2. PubMed ID: 30134785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease in Down syndrome: neurobiology and risk.
    Zigman WB; Lott IT
    Ment Retard Dev Disabil Res Rev; 2007; 13(3):237-46. PubMed ID: 17910085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects.
    Piccoli C; Izzo A; Scrima R; Bonfiglio F; Manco R; Negri R; Quarato G; Cela O; Ripoli M; Prisco M; Gentile F; Calì G; Pinton P; Conti A; Nitsch L; Capitanio N
    Hum Mol Genet; 2013 Mar; 22(6):1218-32. PubMed ID: 23257287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and Down syndrome. Do antioxidants play a role in therapy?
    Muchová J; Žitňanová I; Ďuračková Z
    Physiol Res; 2014; 63(5):535-42. PubMed ID: 24908086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Shape of Mitochondrial Dysfunction in Down Syndrome.
    Zamponi E; Helguera PR
    Dev Neurobiol; 2019 Jul; 79(7):613-621. PubMed ID: 30830726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutics for mitochondrial dysfunction-linked diseases in Down syndrome.
    Ganguly BB; Kadam NN
    Mitochondrion; 2023 Jan; 68():25-43. PubMed ID: 36371073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease.
    Percy ME; Dalton AJ; Markovic VD; McLachlan DR; Hummel JT; Rusk AC; Andrews DF
    Am J Med Genet; 1990 Apr; 35(4):459-67. PubMed ID: 2139757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.
    Valenti D; de Bari L; De Filippis B; Henrion-Caude A; Vacca RA
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():202-17. PubMed ID: 24548784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil oxidative metabolism in Down syndrome patients with congenital heart defects.
    Akinci O; Mihci E; Tacoy S; Kardelen F; Keser I; Aslan M
    Environ Mol Mutagen; 2010 Jan; 51(1):57-63. PubMed ID: 19593803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.